Chroma Medicine

Chroma Medicine is developing epigenetic medicines to revolutionize the treatment of genetic diseases. Epigenetics refers to the diverse ways in which the expression of genes can be regulated. Chroma is exploiting these natural gatekeeper mechanisms of gene expression to develop genomic medicines without changing the sequence of DNA. Chroma’s programmable epigenetic editors can target a specific genomic loci of therapeutic interest and either silence or activate the gene. The epigenetic changes made are specific and durable offering the potential for single-dose medicines. Chroma’s programmable and modular platform positions them to many therapeutic possibilities for which they hope to cure patients suffering from serious illnesses.

Jobs: